4Zinck SE, Schwartz E, Berry GJ, et al. CT of noninfectious granulomatous lung disease. Radiol Clin North Am, 2001, 39: 1189-1209.
5Chiles C. Imaging features of thoracic sarcoidosis. Semin Roentgenol, 2002,37:82-93.
6Armstrong P, Wilson AG, Dee P, eds. Imaging of disease of the chest. 3rd ed. London: Mosby, 2000.640-652.
7Sider L, Horton ES Jr. Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography. J Thorac Imaging, 1990,5:77-80.
8Gawne-Cain ML, Hansell DM. The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study. Clin Radiol, 1996, 51: 263-267.
2Costabel U, Guzman J, Drent M. Diagnosis approach to sarcoidosis[J]. Eur Respir Monograph,2005, 10:259 264.
3Reichenberger F, Schauer J, Kellner K, et al . Different expression of endothelin in the broncho-alveolar lavage diseases [ J]. Lung, 2001,179 (3) :1632174.
4JaskiewiczK, RzepkoR, DubaniewiczA, et al. Pregranulomatousphase of sarcoidosis : immunohistochemical diagnosis [ J ]. Acta Histochem, 2006,107 (6) :4732477.
5FreitasS, CordeiroR, OliveiraC, et al. Areinflammatorypatterns corre- lated to CD4/ CD8 ratio in sarcoidosis .9 [ J ]. RevPort Pnemol, 2003,9 (5 Suppl) :38.
6Semenzato G, Bortoli M, Brunetti E, et al. Immunology and patho- physiology [ J ]. In : European Respiratory Monography on Sarcoido- sis ,2006,10 ( monograph 32 ) :49.
7Charlier C, Nunes H, Trinchet JC, et al. Evolution of previous sar- coidosisunder type 1 interferons given for severe associated disease [J]. Eur Respir J ,2005,25:570.
8Perez RL, Kimani AP, King TE, et al. Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis [ J ]. Respiration, 2007,74 : 297.
